Summary of Significant Accounting Policies - Additional Information (Details)1 |
12 Months Ended |
|---|---|
Dec. 31, 2024 | |
| IKENA ONCOLOGY INC | |
| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
| Revenue, remaining performance obligation, expected timing of satisfaction, explanation | Amounts expected to be recognized as revenue within the 12 months following the balance sheet date are classified as current portion of deferred revenue in the accompanying consolidated balance sheets. Amounts not expected to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current portion. |